The RESOLUTION Microbial Genotyping System is based on PathoGenetix’s proprietary Genome Sequence Scanning™ (GSS™) technology, a breakthrough in microbial identification with significant advantages for food safety testing. GSS works directly from complex mixtures such as enriched food samples, and automates the identification process from sample preparation to final result to provide actionable information in just five hours, days faster than identification methods currently in use in the food industry.
Q Laboratories, Inc. participated in PathoGenetix’s RESOLUTION Customer Experience Program in November, where it received an initial in-depth, hands-on review of the GSS technology. PathoGenetix’s first round of evaluations for the RESOLUTION System has focused on leading contract testing laboratories serving the food safety industry. Many food producers worldwide rely on these third party laboratories for all or part of their food quality and safety testing programs.
“We are extremely pleased to be conducting onsite evaluations of the RESOLUTION Systems by highly experienced, industry-leading food contract testing labs such as Q Laboratories,” said John Czajka, PhD, PathoGenetix’s Vice President of Business Development. “These evaluations are demonstrating the speed and accuracy of the RESOLUTION System, and providing key end-user feedback on its fit and function within high-volume laboratory workflows.”
Additionally, the U.S. Food and Drug Administration (FDA) has recently begun a nine month lease of RESOLUTION System to evaluate the System for use in public health foodborne illness outbreak investigation and response as part of a three year collaboration between the FDA and PathoGenetix.
